Enabling Oral Delivery of Sensitive Molecules

July 15, 2015 - 8:00am

Enteric capsule drug delivery technology (ECDDT) was developed to provide oral delivery with full enteric protection and rapid release in the GI tract without the use of coatings. ECDDT’s intrinsically enteric properties are attained by incorporating pharmaceutically approved enteric polymers in the capsule shell using conventional capsule manufacturing processes. By eliminating the  need for enteric coating, ECDDT can enable the oral delivery of sensitive molecules, such as nucleotides and peptides, biological products such as vaccines, and live biotherapeutic products (LBPs), which can degrade at the high temperatures or can be sensitive to aqueous coating solution associated with coating processes.

Presented by: Hassan Benameur, Ph.D.

 

View the presentation by clicking the play button in the video below.

 

Topics: 
Modified & Targeted Release